Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation

BLOOD CANCER JOURNAL(2022)

Cited 8|Views26
No score
Key words
Chronic myeloid leukaemia,Genetics research,Innate immunity,Risk factors,Biomedicine,general,Cancer Research,Oncology,Hematology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined